Literature DB >> 12495795

A novel cognitive-behavioral approach for treatment-resistant drug dependence.

Mark H Pollack1, Susan A Penava, Elisa Bolton, John J Worthington, Gretchen Lanka Allen, Francisco J Farach, Michael W Otto.   

Abstract

Despite the application of treatments that combine methadone administration, weekly counseling, and contingency reinforcement strategies, many opiate-dependent patients continue illicit drug use. In this controlled study we piloted a novel cognitive-behavioral treatment (CBT) designed to reduce illicit drug use among patients receiving methadone treatment. The treatment targeted the reduction of sensitivity to interoceptive cues associated with drug craving, and trained alternative responses to these cues. Patients (N = 23) were randomly assigned to either this novel CBT program or a program of increased counseling, such that the two programs of treatment were equated for therapist contact, assessment time, and contingency-reinforcement strategies. We found that, compared to a doubling of contact with their outpatient counselor, the new program was associated with significantly greater reductions in illicit drug use for women, but not for men. Reasons for differential performance by women and men and future directions for this new treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495795     DOI: 10.1016/s0740-5472(02)00298-2

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  13 in total

1.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  Anxiety sensitivity and illicit sedative use among opiate-dependent women and men.

Authors:  Bridget A Hearon; Amanda W Calkins; Daniella M Halperin; R Kathryn McHugh; Heather W Murray; Michael W Otto
Journal:  Am J Drug Alcohol Abuse       Date:  2010-11-19       Impact factor: 3.829

3.  Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain.

Authors:  R Kathryn McHugh; Roger D Weiss; Marise Cornelius; Marc O Martel; Robert N Jamison; Robert R Edwards
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

4.  Deepened extinction following compound stimulus presentation: noradrenergic modulation.

Authors:  Patricia H Janak; Laura H Corbit
Journal:  Learn Mem       Date:  2010-12-14       Impact factor: 2.460

Review 5.  Cognitive behavioral therapy for substance use disorders.

Authors:  R Kathryn McHugh; Bridget A Hearon; Michael W Otto
Journal:  Psychiatr Clin North Am       Date:  2010-09

6.  Development of a brief substance use sensation seeking scale: validation and prediction of injection-related behaviors.

Authors:  Dan Werb; Chris Richardson; Jane Buxton; Jeannie Shoveller; Evan Wood; Thomas Kerr
Journal:  AIDS Behav       Date:  2015-02

Review 7.  Spending on substance abuse treatment: how much is enough?

Authors:  Ellen Meara; Richard G Frank
Journal:  Addiction       Date:  2005-09       Impact factor: 6.526

8.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

9.  A randomized clinical trial of a tailored behavioral smoking cessation preparation program.

Authors:  Danielle E McCarthy; Krysten W Bold; Haruka Minami; Vivian M Yeh
Journal:  Behav Res Ther       Date:  2015-12-15

10.  Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.

Authors:  Michael W Otto; Conall M O' Cleirigh; Mark H Pollack
Journal:  Sci Pract Perspect       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.